1/22/2024 0 Comments Ortho clinical diagnostics vitros![]() ![]() et al., Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction Circulation. ![]() Comparison of 13 Commercially Available Cardiac Troponin Assays in a Multicenter North American Study. Combined neprilysin and renin-angiotensin system inhibition for the treatment of heart failure. doi:10.1093/eurheartj/ehi631ĨVardeny O, Miller R, Solomon SD. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. We never stop innovating to offer streamlined, sustainable laboratory solutions that deliver fast, accurate, reliable test results to support exceptional patient care. doi:10.1016/j.amjcard.2004.12.032ħJanuzzi JL, van Kimmenade R, Lainchbury J, et al. Ortho Clinical Diagnostics is a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: The Valsartan Heart Failure (Val-HeFT) data. Natriuretic peptide testing in heart failure. Head-to-head comparison of 10 natriuretic peptide assays. doi:10.1161/CIRCULATIONAHA.114.013748ģCollin-Chavagnac D, Dehoux M, Schellenberg F, Cauliez B, Maupas-Schwalm F, Lefevre G Société Française de Biologie Clinique Cardiac Markers Working Group. ![]() Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. We are proud to introduce industry-changing products like our VITROS XT Solutions designed to help them succeed by driving efficiencies, reducing costs and improving patient outcomes.1Mueller T, Gegenhuber A, Dieplinger B, Poelz W, Haltmayer M. “Our team has spent countless hours speaking with lab directors and decision makers across hospitals, health care systems, and emergency departments to truly understand their realities and challenges. Ortho clinical labs product portfolio head Piper Antimarino said: “Like many industries, the diagnostic space is under constant pressure to do more with less, and often, that starts in the lab, the hub of the health care journey. ![]() Ortho said that its newly launched VITROS XT 3400 Chemistry System has been granted CE Mark approval, and is available for purchase in various countries. The double assay processing is said to offer a 25% faster turnaround time on a common panel of assays, taking an average of 7.5min processing time, compared to other options, which would take around 10min. It allows for a lowest sample volume of 2.7μl. VITROS XT MicroSlide is a multi-layered slide in the size of a postage-stamp, which filters out lipids and proteins to avoid the drop in quality of results, and offers superior throughput than other available slides. The new VITROS XT 3400 Chemistry System, similar to the VITROS XT 7600 Integrated System, would simultaneously perform two tests ordered together on one VITROS XT MicroSlide. “Driven by this, we work diligently to ensure the world’s labs are best equipped to partner with clinicians and medical teams to provide consistently fast, accurate results that help them confidently diagnose, monitor and treat their patients.” Ortho secured CE Mark approval for VITROS XT 3400 Chemistry System Ortho Clinical Diagnostics chief executive officer Chris Smith said: “Because Every Test is a Life, we make patient care our passion at Ortho Clinical Diagnostics. VITROS XT Solutions, with the new VITROS XT 3400 Chemistry System and the VITROS XT 7600 Integrated System with new XT MicroSlides, will offer consistent, fast, accurate and reliable results, said the company. US-based diagnostics firm Ortho Clinical Diagnostics has launched VITROS XT 3400 Chemistry System, to enhance its VITROS XT Solutions, a comprehensive suite of solutions for diagnostics labs. Ortho Clinical Diagnostics launched VITROS XT 3400 Chemistry System. The new VITROS XT 3400 Chemistry System will simultaneously perform two tests ordered together on one VITROS XT MicroSlide ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |